Suivre
Dr. Stephan Röskam
Dr. Stephan Röskam
Head of Quality- and Process Management & Organisation Development, Rotes Kreuz Krankenhaus Bremen
Adresse e-mail validée de roteskreuzkrankenhaus.de
Titre
Citée par
Citée par
Année
Naturally occurring autoantibodies against β-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease
R Dodel, K Balakrishnan, K Keyvani, O Deuster, F Neff, LC Andrei-Selmer, ...
Journal of Neuroscience 31 (15), 5847-5854, 2011
1572011
Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer’s disease 24 h after single treatment
D Mengel, S Röskam, F Neff, K Balakrishnan, O Deuster, M Gold, ...
Translational psychiatry 3 (3), e236-e236, 2013
372013
APP transgenic mice: the effect of active and passive immunotherapy in cognitive tasks
S Röskam, F Neff, R Schwarting, M Bacher, R Dodel
Neuroscience & Biobehavioral Reviews 34 (4), 487-499, 2010
322010
Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
M Gold, D Mengel, S Röskam, R Dodel, JP Bach
Journal of neuroinflammation 10, 1-9, 2013
312013
Enhanced prepulse inhibition of startle using salient prepulses in rats
S Röskam, M Koch
International journal of psychophysiology 60 (1), 10-14, 2006
252006
Effects of neonatal and peripubertal ethanol treatment on various aspects of adult rat behavior and brain anatomy
S Röskam, M Koch
International Journal of Developmental Neuroscience 27 (3), 249-256, 2009
192009
Evaluating the murine anti-human antibody response and assessment of general activity and cognition after treatment with human intravenous immunoglobulins in healthy adult C57 …
I Fülber, M Bacher, R Dodel, S Röskam
European Journal of Inflammation 12 (3), 489-497, 2014
62014
The multi-target effects of cni-1493: Convergence of antiamylodogenic and antiinflammatory properties in animal models of alzheimer’s disease
R Sankowski, A Herring, K Keyvani, K Frenzel, J Wu, S Röskam, ...
Molecular Medicine 22, 776-788, 2016
32016
Evaluation of the murine anti-human antibody response and assessment of general activity and cognition after treatment with human intravenous immunoglobulins in healthy adult mice
S Röskam, I Fuelber, M Bacher, R Dodel
BEHAVIOURAL PHARMACOLOGY 22, E44-E44, 2011
2011
Single immunization with human naturally occurring autoantibodies against beta amyloid after 24 h leads to enhanced synapse formation and restores cognitive deficits in Tg2576 mice
S Röskam, D Mengel, F Neff, M Bacher, R Dodel
Alzheimer's and Dementia 7 (4), 5, 2011
2011
P2‐484: The MAP kinase inhibitor drug CNI‐1493 leads to cognitive improvement in an animal model of AD after 24 hours
D Mengel, JP Bach, K Balakrishnan, S Röskam, M Gold, R Sankowski, ...
Alzheimer's & Dementia 7, S467-S467, 2011
2011
Passive immunization with natural occurring anti-abeta antibodies leads to differential effects on cognition in APP transgenic mice
S Röskam, S Haake, M Bacher, R Dodel
Alzheimer's & Dementia: The Journal of the Alzheimer's Association 5 (4 …, 2009
2009
Pubertäre chronische Ethanolbehandlung nach neonataler Ethanol-Applikation: Effekte auf emotionale, kognitive und perzeptuelle Verhaltensleistungen der Ratte
S Röskam
Universität Bremen, 2006
2006
In Vivo Detection of Alzheimer Disease in APP Transgenic Mice with T2-Mapping
MN Voelker, S Roeskam, AM Koenig, R Dodel, JT Heverhagen
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–14